High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases.
D001327:Autoimmune Diseases / Q000628:therapy*; D054598:Blue Cross Blue Shield Insurance Plans; D002469:Cell Separation / Q000295:instrumentation; D002986:Clinical Trials as Topic; D018795:Device Approval; D017277:Drug Approval; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014481:United States; D014486:United States Food and Drug Administration